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 The lens is a highly organized and polarized tissue.
Growth and development of the lens depend on proper spatial
regulation of cell proliferation and differentiation [1-3]. The
central lens epithelial cells are relatively quiescent while the
epithelial cells near the periphery (the germinative zone) show
a higher proliferative index. As the epithelial cells in the ger-
minative zone proliferate, cells posterior to this zone are pushed
into the transitional zone where they are induced to elongate
and differentiate into the lens fiber cells. The newly differen-
tiated fiber cells accumulate in a concentric manner on top of
the previously differentiated fiber cells in the bow region. As
the immature fiber cells migrate toward the lens core, their
nuclei and intracellular organelles degrade to result in mature
fiber cells [4].
Growth factors have been implicated as regulators of cell
proliferation and differentiation during lens development [1,3].
Gain-of-function studies in mice show that fibroblast growth
factors (FGFs) can function as differentiation inducers, while
platelet-derived growth factors (PDGFs) function mainly as
mitogens [5-8]. The function of insulin and insulin-like growth
factors (IGFs) is unclear. Experiments in chicken lens epithe-
lial explants show that insulin and IGFs can induce epithelial-
to-fiber differentiation, as measured by cell elongation and an
increase in δ-crystallin synthesis [9,10]. In contrast, insulin
and IGFs were weak differentiation factors for rat lens epithe-
lial cells in explant cultures. However, these growth factors
appeared capable of enhancing or maintaining the differentia-
tion phenotype induced by FGF [11-13]. In transgenic mice
generated to overexpress IGF-1 in the lens by means of the
mouse αA-crystallin promoter [14], lens epithelial cells were
found to not undergo premature differentiation, which is con-
sistent with the observation that IGF-1 itself is not a differen-
tiation inducer in rodent lens explants. Interestingly, the lens
growth pattern in IGF-1 mice was perturbed and the lens epi-
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thelial compartment was extended more posteriorly than in
normal mice.
Insulin and IGF-1 act through two related cell surface re-
ceptors, insulin receptor (IR) and IGF-1 receptor (IGF-1R)
[15]. These two receptors have a high degree of sequence simi-
larity and both are expressed in most mammalian cell types,
although at different levels [16]. Each receptor has a high af-
finity for its cognate ligand, whereas the binding affinities of
insulin to IGF-1R and IGF-1 to IR are about 100 fold lower
[17,18]. Interestingly, although IR and IGF-1R are highly con-
served from a structural standpoint and share common intrac-
ellular signaling pathways, their in vivo physiological func-
tions are quite distinct. IR is primarily important for fuel me-
tabolism, while IGF-1R is primarily important for cell growth
[19,20]. There are two main intracellular pathways that are
activated by insulin and IGF-1 receptors: the insulin receptor
substrate (IRS)-phosphatidylinositol 3-kinase (PI3K) pathway
and the Ras-mitogen-activated protein kinase (MAPK) path-
way [20-22]. The IRS-PI3K pathway leads to the activation
of the three Akt isoforms [23]. Activated Akt can phosphory-
late glycogen synthase kinase 3 (GSK3) [24], pro-apoptotic
protein BAD [25,26], and transcription factor FOXO [27-29],
leading to stimulation of glycogen synthesis, cell survival, and
gene expression, respectively. Activation of the Ras-MAPK
pathway occurs through the recruitment of the SH2-domain
proteins Shc, Grb2, and the exchange factor SOS (son of
sevenless) [30,31]. The current consensus, which probably
constitutes an oversimplified model, is that the acute meta-
bolic effects of insulin require activation of the IRS-PI3K path-
way, while stimulation of cell growth and proliferation requires
the Ras-MAPK cascade.
Gene knockout experiments have provided further evi-
dence that IR and IGF-1R have overlapping yet diverse func-
tions in embryonic development [15,32]. Mice lacking either
IR or IGF-1R are born with growth retardation of different
severity. IGF-1R-null newborn mice are 45% of normal weight,
whereas IR-null mice are 90% of normal weight [33-37]. IGF-
1R null mice are born with multiple abnormalities, including
hypoplastic muscles, delayed bone development, and thin epi-
dermis, and die immediately after birth [33,34]. In contrast,
IR null mice develop severe diabetes at an early postnatal age
and die of diabetic ketoacidosis, suggesting that IR action is
essential for postnatal fuel metabolism and this function can-
not be substituted by IGF-1R [35]. Lens defects have not been
reported in these gene knockout mice.
Lens epithelial cells in explants respond to either IGF-1
or insulin in a similar fashion [12]. To gain further understand-
ing of the function of these growth factors in lens develop-
ment, we generated transgenic mice that overexpress insulin
in the lens with two different promoters: the mouse αA-crys-
tallin promoter and the newly developed δenαA-promoter.
With the αA-crystallin promoter, transgene expression was
restricted to the lens fiber cells, whereas the δenαA-promoter
directed expression in both lens epithelial and fiber cells [38].
Analysis of the transgenic mice has revealed that the severity
of the lens defects was dependent on the transgene expression
level rather than the cell-specific expression pattern. Like IGF-
1, insulin expression did not induce premature differentiation
of lens epithelial cells [14]. Interestingly, insulin expression
caused an anterior shift and expansion of the transitional zone
and an inhibition of fiber cell terminal differentiation.
METHODS
RNA isolation and RT-PCR:  All animals were used in accor-
dance with the Association of Research in Vision and Oph-
thalmology (ARVO) Statement for the Use of Animals in
Ophthalmic and Vision Research, which is comparable to the
animal care guidelines of the Institute of Laboratory Animal
Research. Wild type (FVB/N) mouse lenses were obtained at
embryonic day 15.5 (E15.5) or at birth (P0), and homogenized
in TRI REAGENT (Sigma, St. Louis, MO) to extract total
RNA, following the manufacturer’s instructions. Reverse tran-
scriptase-polymerase chain reaction (RT-PCR) was performed
on 10 ng total lens RNA using the OneStep RT-PCR kit from
Qiagen (Valencia, CA). For mouse IGF-1R (GenBank
NM_010513), sense (5'-GAG GAC TGT CAT CTC CAA CC-
3') and antisense (5'-CGA TTC TTT CAC GCA TAC TTG C-
3') primers were used to amplify a 778 base pair (bp) cDNA
fragment. For mouse IR (GenBank NM_010568), the sense
(5'-GAA GAT CAC CCT TCT TCG AG-3') and antisense (5'-
CAG TGA GTC TCT CTG GAC AG-3') primers generated a
fragment of 736 bp. PCR products were run on a 2% agarose
gel and stained with ethidium bromide for visualization under
ultraviolet (UV) light. The PCR fragments were cloned into
the pCRII-TOPO cloning vectors (Invitrogen, Carlsbad, CA)
and sequenced to verify their identities. These plasmids were
also used to generate riboprobes for in situ hybridization to
detect the expression patterns of IR and IGF-1R in the mouse
lens.
Histology:  Embryonic heads and postnatal eyes were re-
moved from mice and fixed overnight in 10% neutral buff-
ered formalin. The samples were briefly rinsed twice with
phosphate buffered saline (PBS), dehydrated in a series of in-
creasing concentrations of ethanol, cleared in xylene, and
embedded in paraffin. Sections were cut at 5 µm, de-waxed
with xylene, rehydrated with a series of decreasing concentra-
tions of ethanol, and processed for hematoxylin and eosin
(H&E) staining, in situ hybridization, or immunohistochem-
istry.
In situ hybridization:  The procedure for in situ hybrid-
ization was described previously [39]. Briefly, radioactive 35S-
labeled riboprobes were synthesized in vitro from linearized
pCRII-TOPO plasmids containing the cDNA for either IR or
IGF-1R. After overnight hybridization, the slides were washed,
digested with RNase A, and washed again to remove
unhybridized probes. Slides were coated with Kodak NTB-2
emulsion and exposed at 4 °C for a week. After developing
the slides in the Kodak D-19 developer, the sections were coun-
terstained with hematoxylin. The bright- and dark-field im-
ages were captured by a CCD camera.
BrdU incorporation assay:  Pregnant females were in-
jected intraperitoneally with 100 ng of 5-bromo-2'-
deoxyuridine (BrdU; Sigma, St. Louis, MO) and 6.7 ng of
fluoro-deoxyuridine (FldU, Sigma) per gram of body weight.
398After 1 h, mice were sacrificed and embryos were collected
for BrdU immunohistochemistry, as described previously [40].
Immunohistochemistry:  Immunostaining was performed
as previously described [40,41]. Briefly, tissue sections were
incubated with blocking solution (5% non-immune serum in
phosphate buffered saline [PBS]) for 30 min at room tem-
perature and then with primary antibodies overnight at 4 °C.
The source and dilution ratio for each primary antibody are as
follows: anti-BrdU (1:100; Dako, Carpinteria, CA), anti α-,
β- or γ-crystallins (gifts from Dr. Samuel Zigler at the Na-
tional Eye Institute; 1:500, 1:1000, or 1:2000, respectively),
anti-cytochrome c oxidase (COX) subunit I (catalog number
A6403, 1:200; Molecular Probes, Eugene, OR), anti-protein
disulfide isomerase (PDI, 1:200; Stressgen, Victoria, BC
Canada), anti-phospho-ERK (pERK) and anti-Shc (1:100; Cell
Signaling, Danvers, MA). After washing with PBS, sections
were incubated with biotinylated (Vector Laboratories) or fluo-
rescein-conjugated (Molecular Probes) secondary antibodies
for 1 h at room temperature and then washed with PBS twice.
For immunofluorescent staining, cell nuclei were stained with
300 nM 4',6-diaminino-2-phenylindole (DAPI; Molecular
Probes) for 10 min at room temperature. Sections were rinsed
twice with PBS, mounted in coverslips with 50% glycerol in
PBS, and examined under UV illumination. Alternatively, for
color detection of immunogens, an avidin-biotin-peroxidase
complex (ABC) method was used (kit PK-4002; Vector Labo-
ratories, Burlingame, CA) with diaminobenzidine-H2O2 as a
substrate (Sigma). Sections were counterstained with hema-
toxylin.
Western blot analysis:  Newborn mouse lenses were iso-
lated and homogenized in RIPA buffer containing 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS, 0.02% sodium
orthovanadate, and 2 mM DTT in PBS. Protease inhibitors
(Set III kit from Calbiochem, San Diego, CA) and phosphatase
inhibitors (Set II kit from Calbiochem) were added freshly
each time. After centrifugation at 10,000 rpm for 5 min, the
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Figure 1. Expression of IR and IGF-1R in mouse lens.  A: RT-PCR was used to detect IR and IGF-1R expression in embryonic day 15.5
(E15.5) and newborn (P0) mouse lenses. Expression patterns of IGF-1R (B) and IR (C) in newborn mouse lens were detected by in situ
hybridization. IR sense probe was used as a negative control to monitor the background signal (D). Both IGF-1R and IR are expressed in the
peripheral region of the lens (arrows in B and C). The IGF-1R signal was stronger than IR in the lens. Other tissues in the eye, including the
cornea and retina, also express IGF-1R and IR. A high level of IR mRNA was found in the blood vessel cells surrounding the lens (arrowheads
in C). Abbreviations used: epi, lens epithelial cells; fib, lens fiber cells. Scale bars in all the figures represent 100 µm.
399supernatant was removed and an aliquot was taken for protein
determination using the BCA method [42]. For crystallin as-
says, 10 µg of protein were denatured in 2X SDS sample buffer
and boiled for 5 min before loading. For other antigens re-
ported in this study, 100 µg of total lens protein were used.
Proteins were separated on 4-12% gradient gels by SDS-PAGE
and transferred onto a polyvinylidene difluoride (PVDF) mem-
brane (Invitrogen). The blots were immersed in blocking buffer
for 1 h, and then incubated with the primary antibody at 4 °C
overnight. The dilution ratios for anti α-, β-, and γ-crystallin
primary antibody were 1:3000, 1:6000, and 1:10,000, respec-
tively. Antibodies against ERK, pERK, Akt, pAKT (Cell Sig-
naling), and PDI (Stressgen) were diluted according to the
manufacturer’s instructions. After washing, the blots were in-
cubated with secondary antibody for 1 h at room temperature,
and the antibodies were detected by enhanced chemilumines-
cence (ECL). Western blotting against β-actin (Sigma) was
used as a control to assess equal protein loading.
RESULTS
IR and IGF-1R expression in mouse lens:  Lens epithelial cells
in explant cultures respond to both insulin and IGF stimula-
tion, implying that these cells express receptors and signaling
components for these growth factors [12,13,43]. IR and IGF-
1R transcripts were detected by RT-PCR in E15.5 and new-
born lenses (Figure 1A). To examine the expression patterns
of these two receptors within the lens, in situ hybridizations
were done using newborn mouse lenses (Figure 1B-D). IR
and IGF-1R were expressed mainly in the lens germinative
and transitional zones. Signals for IR were weaker than those
for IGF-1R (Figure 1B,C). IR and IGF-1R expression was also
detected in the developing retina, iris, ciliary body, and cor-
nea (Figure 1B,C). Interestingly, the vascular endothelial cells
outside the lens expressed IR at a higher level than IGF-1R
(arrowheads in Figure 1C).
Lens defects in insulin-expressing transgenic mice:  The
two types of promoters used in this study were the mouse αA-
crystallin promoter (αA) and a modified αA-promoter linked
to the δ1-crystallin enhancer (δenαA). In the two αA-insulin
transgenic families (OVE441 and OVE442), transgene mRNA
was detected only in the lens fiber cells [38]. In contrast,
transgenic mice made with the modified δenαA promoter
showed high levels of transgene expression in both lens epi-
thelial and fiber cells [38]. A total of six δenαA-insulin
transgenic families were established and named LR12, LR13,
LR14, LR16, LR20, and LR22.
Transgenic mice from each family except LR20 had vis-
ible cataracts when they opened their eyes at postnatal day 14
(P14). Mice from family LR20 eventually developed cataracts
at 4 months of age. In situ hybridization showed that the
transgene was weakly expressed in this family (data not
shown). In the families with the highest levels of transgene
expression, OVE442 and LR22, the eyes were microphthalmic.
The transgenic lenses from families OVE442 and LR22
were compared to those of wild type mice (Figure 2). New-
born (P0) wild type lenses were round and transparent, whereas
the OVE442 and LR22 lenses were cloudy and did not have a
normal spherical shape (Figure 2). Changes in lens shape were
not apparent in the other transgenic families. In addition to
the lens defects, transgenic mice in most of the families had
abnormalities in their ocular vasculature. There was an over-
growth and persistence of the tunica vasculosa lentis (TVL),
particularly around the posterior pole of the lens (Figure 2).
The vascular defects in the transgenic mice will be described
in another article.
Histological analysis showed that the severity of the lens
defects correlated with the transgene expression level (Figure
3). Disruptions of normal lens structure were apparent at birth.
In the mildly affected family LR12, the lens epithelium and
cortex looked normal. However, morphologic changes were
seen in the central fiber cells in the LR12 family and in the
other transgenic families. Fiber cells failed to elongate com-
pletely and did not contact the anterior epithelial layer, result-
ing in the formation of a subcapsular lumen (Figure 3, aster-
isks). In addition, most of the central fiber cells retained their
cell nuclei, indicating a disruption in normal fiber cell differ-
entiation. Additional changes were observed in the severely
affected families (OVE442 and LR22). First, the lens transi-
tional zone was expanded (as marked with brackets in Figure
3). Second, there was an abnormal “bow pattern” (the arc-
shaped path of fiber cell nuclei). Despite the severe defects in
the lens fiber cells, the epithelial cells in transgenic mice looked
relatively normal.
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Figure 2. Lens morphology in wild type (WT), OVE442, and LR22
transgenic mice.  Lenses were isolated from newborn (P0) mice for
examination and photography. Some ciliary body tissues (arrows)
were left on the lens to avoid damage or distortion to the lens during
dissection. The WT lenses are transparent and spherical in shape.
The transgenic lenses are cloudy and show a distorted shape. Addi-
tionally, there is an excess growth of the blood vessels at the poste-
rior pole of the transgenic lenses (arrowheads).
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Figure 3. Lens histology in
wild type (WT) and transgenic
lines OVE442, LR12, and
LR22 at birth.  Fiber cell elon-
gation was defective in all
transgenic families, resulting
in the presence of a subepithe-
lial lumen (marked with aster-
isks). In the mildly affected
line LR12, the lens polarity and
the transitional zone (t) look
normal. In the two severely af-
fected lines (OVE442 and
LR22), the transitional zone (t)
is shifted anteriorly and is dra-
matically expanded (as shown
in brackets).
Figure 4. Cell proliferation in
wild type (WT) and OVE442
transgenic mouse lenses.  Lens
cells at S-phase of the cell
cycle were monitored with
BrdU-labeling. BrdU-positive
cells (brown nuclei) are distrib-
uted across the epithelial layer
in the WT lenses (A, C) and
OVE442 transgenic lenses (B,
D). At E15.5 (A, B), the per-
centage of BrdU-positive nu-
clei is similar in the WT and
transgenic lenses. At E18.5 (C,
D), the percentage of BrdU-
positive cells is slightly re-
duced in the transgenic lens,
correlating with the phenotype
of a reduced lens epithelial cell
compartment.
401Cell proliferation:  The anterior shift of the lens transi-
tional zone suggested that insulin overexpression might affect
cell proliferation and differentiation in the transgenic lenses.
BrdU labeling was performed to detect the lens cells in S-
phase of the cell cycle (Figure 4). In wild type lenses, BrdU-
positive cells were distributed across the lens epithelial layer
(Figure 4A,C). At E15.5, the BrdU labeling pattern was es-
sentially the same between the wild type and the transgenic
lenses (Figure 4A,B and Table 1). At E18.5, when the lens
phenotype began to develop, cell proliferation was affected
(Table 1). The total number and percentage of BrdU-positive
cells in the lens epithelial compartment were reduced in the
OVE442 transgenic mice as compared to wild type mice (Table
1). This difference was statistically significant. In the wild type
lens, BrdU-labeled cells were elevated near the germinative
zone, where cell proliferation was most active (Figure 4C).
Such an increase was not obvious in the transgenic lenses (Fig-
ure 4D). We also noted an anterior shift of the transitional
zone in the transgenic lenses. This change was consistent with
the reduction in the total number of lens epithelial cells. The
data suggest that insulin overexpression results in an anterior
shift of the differentiation zone in conjunction with a decrease
in cell proliferation and a reduction of the lens epithelial layer.
Crystallin expression:  To assess the differentiation state
of the transgenic lens, crystallin expression patterns and lev-
els were examined in wild type and OVE442 transgenic mice
(Figure 5). We found that α-crystallin expression was not al-
tered (Figure 5A,D). In the transgenic lenses, β-crystallin ex-
pression was activated slightly earlier than normal (Figure 5E).
This finding is consistent with the observation that the transi-
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Figure 5. Crystallin expression detected by immunohistochemical staining and western blot.  Eye sections of postnatal day 3 (P3) wild type
(A-C) and OVE442 transgenic (D-F) mice were stained for α- (A, D), β- (B, E), and γ- (C, F) crystallins. In both genotypes, α-crystallin is
expressed in all the lens cells, while β- and γ-crystallin are in the lens fiber cells. The space between the two arrows in (C) and (F) illustrate the
area where γ-crystallin expression is absent. This area is expanded in the transgenic lens (F). With western blot analysis for α-, β-, and γ-
crystallin (G), there was no detectable difference in the levels of crystallins between the wild type and transgenic mice. β-Actin was used as a
control for protein loading.
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Figure 6. Fiber cell denucleation in newborn wild type (WT), OVE442 and LR22 mouse lenses.  Newborn eye sections were stained with
DAPI to reveal the distribution of cell nuclei. In the WT lens (A, D), fiber cell maturation is associated with denucleation and formation of a
nuclear-free zone (arrows mark the margin of the area). In OVE442 (B, E) and LR22 (C, F) transgenic lenses, fiber cell nuclei are present
across the entire lens section.
Figure 7. Detection of COX and PDI proteins.
In the WT E18.5 lens (A), COX protein was de-
tected in the epithelial cells and in the secondary
fiber cells at the cortex. Strong COX-
immunostaining was seen in the anterior tips of
the secondary fiber cells (A, arrow). COX-stain-
ing was enhanced in the transgenic lens (B), par-
ticularly in the central region of the lens, where
concentrated COX-staining was seen (B, down-
ward arrows). PDI (rhodamine fluorescence in
red) is highly expressed in the lens epithelial cells
and cortical fiber cells in WT lens (C). PDI stain-
ing is lost in the central fiber cells (C, circled
area). In contrast, PDI expression persists in all
the lens fiber cells in OVE442 transgenic mice
(D). E: PDI western blot analysis on newborn
(P0) and postnatal day 6 (P6) lens. Compared to
the PDI protein level in the WT lenses, expres-
sion is increased significantly in the OVE442
transgenic lenses (E, arrow). The lower band is
from the reactivity of the secondary antibody to
mouse endogenous immunoglobulin protein.
403tional zone was shifted anteriorly in the transgenic lenses. In
contrast to β-crystallin, γ-crystallin expression was delayed in
the transgenic lenses (Figure 5F), suggesting that more fiber
cells were retained in an initial differentiation state, a pattern
consistent with the expansion of the transitional zone in the
transgenic lenses (Figure 3). Although the transgenic lenses
showed altered expression patterns for β- and γ-crystallin, the
total protein levels for all three types of crystallins were simi-
lar in the wild type and transgenic lenses (Figure 5G).
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Figure 8. ERK and Akt protein and phosphorylation levels.  Water-
soluble proteins from newborn lenses were used for western blotting
to detect ERK, phosphorylated ERK (pERK), Akt, and phosphory-
lated Akt (pAkt). The pERK levels (both pERK1 and pERK2) are
increased 2-3 fold in the transgenic lenses while the ERK protein
levels remain the same as that in the WT lenses. No change in Akt or
pAkt levels were detected. The analysis was repeated on three inde-
pendent samples and the results were consistent. β-Actin was used
as a control for protein loading.
Figure 9. Immunohis-
tochemical staining for
pERK and Shc.  In the WT
E18.5 lens, pERK immu-
noreactivity was detected in
the lens epithelial cells at the
germinative zone and in the
newly differentiating fiber
cells (A, arrows). In the
OVE442 transgenic lens,
the pERK-staining area is
expanded in the fiber cells
(B, arrows). The
immunostaining pattern for
the adaptor protein Shc is
also changed in the
transgenic lens. In the WT
lens, Shc is most strongly
expressed in the lens epithe-
lial cells (C, arrows). In the
OVE442 transgenic lens,
strong Shc staining was de-
tected not only in the epi-
thelial layer but also in the
404Fiber cell differentiation and maturation:  During later
stages of differentiation, fiber cells lose their nuclei
(denucleate) and intracellular organelles to form the organelle-
free zone (OFZ) at the lens core [4]. Histology data indicated
impairment of denucleation in the transgenic lenses (Figure
3). To confirm this observation, lens sections of newborn wild
type, OVE442, and LR22 mice were stained with the nuclear
dye DAPI (Figure 6). The OFZ was visible in the wild type
lenses (Figure 6A,D). In contrast, cell nuclei in the transgenic
lenses were distributed across the entire lens (Figure 6B,C,E,F),
suggesting that insulin expression inhibits fiber denucleation.
To examine whether intracellular organelle degradation
was also affected in the transgenic lenses, sections were stained
for cytochrome c oxidase (COX) subunit I and protein disul-
fide isomerase (PDI), which are markers for mitochondria and
endoplasmic reticulum (ER), respectively [44,45]. The mito-
chondrial protein COX was present in both lens epithelial cells
and cortical fiber cells, with high-intensity staining at the an-
terior margin of the fiber cells (Figure 7A). COX staining was
reduced in mature fiber cells. Compared to the wild type lens,
the transgenic lenses exhibited enhanced COX staining (Fig-
ure 7B), particularly in the central region, where strong COX
staining was detected (downward arrows in Figure 7B). The
ER protein PDI was expressed in wild type epithelial cells
and cortical fiber cells. Fiber cells at the center were PDI-
negative in the wild type lens (Figure 7C). In the transgenic
lenses, PDI was expressed in both epithelial cells and fiber
cells, and the level was increased, particularly in the fiber cells
(Figure 7D). Western blot analysis confirmed this observation
(Figure 7E). Taken together, our data suggest that elevated
insulin signaling in the lens interferes with fiber differentia-
tion and maturation.
Signaling pathways affected by insulin overexpression:
Insulin exerts its biological activity through activation of the
insulin receptor (IR). In many different cell types, IR activa-
tion turns on downstream signaling pathways involving Ras
and PI3K, which subsequently activate the Akt kinase and/or
the Raf-MEK-ERK cascade. To explore insulin-activated sig-
naling in the mouse lens, we analyzed the phosphorylation
levels of ERK and Akt by western blot analysis (Figure 8).
The levels of phosphorylated (active) ERK (both pERK1 and
pERK2) were increased 2-3 fold in the transgenic lenses while
the total ERK protein level was unchanged. Surprisingly, phos-
phorylated and total Akt protein levels in the transgenic lenses
were the same as those in the wild type lenses. These results
suggest that the phenotypic changes in the insulin transgenic
lenses are mediated through the ERK, rather than the Akt, sig-
naling pathway.
Increased phospho-ERK levels in the transgenic lenses
were further examined by immunohistochemical staining (Fig-
ure 9A,B). In the E18.5 wild type lens, pERK immunoreac-
tivity was detected both in the cytoplasmic and nuclear com-
partments of cells at the germinative and transitional zones
(Figure 9A). Strong pERK staining was also found at the epi-
thelial-fiber cell apical junctions. The pERK staining pattern
was altered in the transgenic lenses, with the lens cortex show-
ing more pERK-positive fiber cells (Figure 9B). This change
likely accounts for the increased pERK level in the western
blot (Figure 8).
Shc and IRS-1 are two receptor adaptor proteins. These
adaptor proteins bind to the activated receptors at tyrosine
docking sites, are phosphorylated and, in turn, recruit SH2-
domain-containing signaling molecules such as Grb2 and the
p85 regulatory subunit of PI3K [46,47]. Immunostaining for
Shc detected protein expression in the epithelial cells and in
young fiber cells at the cortical region in the wild type lens
(Figure 9C). The Shc protein level sharply decreased to the
background level as fiber cell differentiation proceeded. In
the transgenic lens, the Shc-positive region was expanded into
the cortical fiber cells (Figure 9D). In contrast to Shc, IRS-1
protein was expressed at a much higher level in lens fiber cells
than in epithelial cells, and the staining pattern was similar in
wild type and transgenic lenses (data not shown).
DISCUSSION
 Lens epithelial cells in explants can respond to insulin and
IGF stimulation [9,12,48], suggesting that growth factors in
the insulin/IGF family could potentially regulate cell prolif-
eration and differentiation during normal lens development.
Transgenic mice that overexpress IGF-1 in the lens have been
previously generated [14]. IGF-1 by itself did not function as
a differentiation factor, but it did modify the architecture of
the lens by causing the germinative and transitional zones to
extend toward the posterior pole of the lens. In the current
study, we have generated transgenic mice that overexpress
insulin in lens fiber cells and in both lens epithelial cells and
fiber cells [38]. We found that insulin and IGF-1 transgenic
mice have similar yet distinct phenotypes. Neither insulin nor
IGF-1 was sufficient to induce premature differentiation of
the lens epithelial cells in vivo. This result was consistent with
the findings in rat lens explants where neither IGF nor insulin
alone induced epithelial-to-fiber differentiation [11-13]. El-
evated levels of insulin or IGF-1 produced slight modifica-
tions of the cell proliferation pattern, but the lens epithelium
in both genotypes remained as a monolayer. This result is dif-
ferent from the effect of PDGF-A on lens epithelial cells
[8,49,50].
In both the insulin and IGF-1 transgenic mice, fiber cell
maturation was perturbed and the transitional zone was ex-
panded. An interesting difference was the location of the lens
germinative and transitional zones. In the IGF-1 mice, the lens
epithelial compartment was expanded and the germinative zone
was localized more posterior than in the wild type lens [14].
In contrast, the lens transitional zone was moved anteriorly in
the insulin transgenic mice. These changes correlated with
slight changes in BrdU-labeling in the IGF-1 and insulin mice.
Our data suggest that IGF and insulin are not direct inducers
of fiber cell differentiation. Instead, members of the insulin
growth factor family may play supportive roles in fine tuning
lens growth and differentiation to achieve a normal lens struc-
ture and shape.
It has been shown that one role of Shc in cells is to pro-
mote the formation of a Shc-Grb2-SOS complex, which can
activate the Ras-Raf-MEK-ERK kinase cascade [46]. Previ-
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velopment depends on the activity of the Ras-ERK signaling
pathway [51]. Thus, the slightly enhanced cell proliferation
signal in IGF-1-overexpressing transgenic mice could be ex-
plained by an increase in Ras-ERK signaling activity. In the
lenses of the insulin transgenic mice, we showed that ERK
activity and Shc expression were enhanced in the differentiat-
ing fiber cells (Figure 8 and Figure 9). In contrast, phosphory-
lated Akt and IRS-1 expression were not altered (Figure 8,
and data not shown). It is possible that IR activates additional
signaling pathways, which override the Shc-ERK prolifera-
tion signal and initiate an early epithelial-to-fiber transition.
Analyzing additional signaling pathways may help resolve this
paradox.
In most of the transgenic families (except LR20), fiber
cell differentiation was disrupted by insulin overexpression.
Fiber elongation was incomplete and cell nuclei, mitochon-
dria, and ER were retained in the central fiber cells. Our data
suggest that insulin signaling may antagonize the endogenous
signals that are required for late-stage fiber differentiation. At
present, the molecular mechanisms that regulate fiber cell ter-
minal differentiation, such as denucleation and organelle deg-
radation, have not been defined. Apoptosis-related proteins
may have a role in this process [52,53]. It was recently sug-
gested that the ubiquitin-proteasome pathway might be in-
volved in the breakdown of intracellular organelles during fi-
ber differentiation [54]. We have not investigated whether these
activities are affected in the transgenic lenses. Based on stud-
ies in other systems, IGF and insulin are known to be inhibi-
tors of cell death. Our western blot analysis and
immunostaining showed that ERK phosphorylation was in-
creased, whereas the pAkt level was unaffected in the insulin
transgenic lenses. Therefore, the increased ERK activity could
be contributing to the disruption of the fiber differentiation
program.
In summary, we have demonstrated that insulin
overexpression in the lens is not sufficient to initiate epithe-
lial-to-fiber cell differentiation, but it can alter lens growth
and fiber cell maturation. Combined with the previous study
of the IGF-1 transgenic mice, our data suggest that insulin
and IGF-1 could have overlapping yet distinct functions in
lens development. We propose that, during lens development,
neither IGF-1 nor insulin is a differentiation inducer. Instead,
they function as modifiers of fiber cell morphology. The bal-
ance between IGF-1 and insulin signaling in the lens may help
to finely tune lens growth and maturation. Additionally, our
study suggests that fiber cell terminal differentiation requires
downregulation of insulin-activated signaling pathways. El-
evated ERK activity may antagonize the endogenous apoptotic-
like or proteolytic activities that are involved in late stage fi-
ber cell differentiation.
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